With reference to our earlier intimation dated November 26, 2024, please note that the Company has completed acquisition of an additional 50.49% of total shareholding in TLL Parenterals Limited on December 02, 2024 at 11:45 a.m.
With reference to our earlier intimation dated November 26, 2024, please note that the Company has completed acquisition of an additional 50.49% of total shareholding in TLL Parenterals Limited on December 02, 2024 at 11:45 a.m.